Pentoxifylline for treating venous leg ulcers

School of Nursing, University of Auckland, Private Bag 92019, Auckland, New Zealand.
Cochrane database of systematic reviews (Online) (Impact Factor: 6.03). 12/2012; 12(12):CD001733. DOI: 10.1002/14651858.CD001733.pub3
Source: PubMed


Healing of venous leg ulcers is improved by the use of compression bandaging but some venous ulcers remain unhealed, and some people are unsuitable for compression therapy. Pentoxifylline, a drug which helps blood flow, has been used to treat venous leg ulcers.
To assess the effects of pentoxifylline (oxpentifylline or Trental 400) for treating venous leg ulcers, compared with a placebo or other therapies, in the presence or absence of compression therapy.
For this fifth update we searched the Cochrane Wounds Group Specialised Register (searched 20 July 2012); The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 7); Ovid MEDLINE (2010 to July Week 2 2012); Ovid MEDLINE (In-Process & Other Non-Indexed Citations, July 19, 2012); Ovid EMBASE (2010 to 2012 Week 28); and EBSCO CINAHL (2010 to July 13 2012).
Randomised trials comparing pentoxifylline with placebo or other therapy in the presence or absence of compression, in people with venous leg ulcers.
One review author extracted and summarised details from eligible trials using a coding sheet. One other review author independently verified data extraction.
No new trials were identified for this update. We included twelve trials involving 864 participants. The quality of trials was variable. Eleven trials compared pentoxifylline with placebo or no treatment. Pentoxifylline is more effective than placebo in terms of complete ulcer healing or significant improvement (RR 1.70, 95% CI 1.30 to 2.24). Pentoxifylline plus compression is more effective than placebo plus compression (RR 1.56, 95% CI 1.14 to 2.13). Pentoxifylline in the absence of compression appears to be more effective than placebo or no treatment (RR 2.25, 95% CI 1.49 to 3.39).More adverse effects were reported in people receiving pentoxifylline (RR 1.56, 95% CI 1.10 to 2.22). Nearly three-quarters (72%) of the reported adverse effects were gastrointestinal.
Pentoxifylline is an effective adjunct to compression bandaging for treating venous ulcers and may be effective in the absence of compression. The majority of adverse effects were gastrointestinal disturbances.

Download full-text


Available from: Andrew Jull, Sep 07, 2015

  • Phlebology 07/2013; 29(6). DOI:10.1177/0268355513496990 · 1.77 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this study, we examined the ability of Pentoxifylline (PTX) to prevent sleep deprivation induced memory impairment probably through decreasing oxidative stress. Sleep deprivation was chronically induced 8 hrs/day for 6 weeks in rats using modified multiple platform model. Concurrently, PTX (100 mg/kg) was administered to animals on daily basis. After 6 weeks of treatment, behavioral studies were conducted to test the spatial learning and memory using the Radial Arm Water Maze. Additionally, the hippocampus was dissected; and levels/activities of antioxidant defense biomarkers glutathione reduced (GSH), glutathione oxidized (GSSG), GSH/GSSG ratio, glutathione peroxidase (GPx), catalase, and superoxide dismutase (SOD), were assessed. The results show that chronic sleep deprivation impaired short- and long- term memories, which was prevented by chronic treatment with PTX. Additionally, PTX normalized sleep deprivation-induced reduction in the hippocampus GSH/GSSG ratio (P < 0.05), and activities of GPx, catalase, and SOD (P < 0.05). In conclusion, chronic sleep deprivation induces memory impairment, and treatment with PTX prevented this impairment probably through normalizing antioxidant mechanisms in the hippocampus. © 2013 Wiley Periodicals, Inc.
    Hippocampus 09/2013; 23(9). DOI:10.1002/hipo.22135 · 4.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This literature review serves to develop an evidence-based algorithm for the treatment of venous ulcerations and the development of a guideline to systemically treat venous leg ulcerations (VLUs) that may improve outcomes, restore function of the affected limb, and reduce health care costs. The Cochrane Database and PubMed search engine were utilized to accumulate literature concerning venous ulcerations and their treatment. The most relevant literature was reviewed to develop an algorithm to guide treatment of VLUs. An algorithm was established outlining the use of compression therapy in VLUs present for < 4 weeks. If a wound is present after 4 weeks of therapy and has not reduced in size by ≥ 40%, bilayered living skin equivalents may be indicated. An algorithm was established to guide the treatment of venous ulcerations. By utilizing a systematic approach in treating VLUs, clinical outcomes may be improved. .
    09/2013; 25(9):242-250.
Show more